Mereo BioPharma Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.About MREO
Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).
CEODenise Vera Scots-Knight
CEODenise Vera Scots-Knight
Employees39
Employees39
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2015
Founded2015
Employees39
Employees39
MREO Key Statistics
Market cap50.12M
Market cap50.12M
Price-Earnings ratio-1.76
Price-Earnings ratio-1.76
Dividend yield—
Dividend yield—
Average volume18.21M
Average volume18.21M
High today$0.3146
High today$0.3146
Low today$0.2953
Low today$0.2953
Open price$0.3067
Open price$0.3067
Volume785.80K
Volume785.80K
52 Week high$2.37
52 Week high$2.37
52 Week low$0.20
52 Week low$0.20
MREO News
Simply Wall St 1d
Here's Why We're Not Too Worried About Mereo BioPharma Group's Cash Burn SituationEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although softwar...
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.